Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

AquaVita NextGen vs CoreAge Rx

By GLP-1 ScorecardUpdated

AquaVita NextGen
Site position #465

Lower grade

CoreAge Rx
Site position #1

Higher grade

Score comparison

CoreAge Rx has the higher recorded score — 89.5/100 to 56.3/100.

CoreAge Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

CoreAge Rx scores 89.5/100 (B+).

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueCoreAge Rx +69
23
92
Dose & formulationCoreAge Rx +13
75
88
Clinical oversightCoreAge Rx +11
82
93
Labs & monitoringCoreAge Rx +37
53
90
FulfillmentCoreAge Rx +33
62
95
Contract termsCoreAge Rx +20
47
67
AquaVita NextGen · top barCoreAge Rx · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricAquaVita NextGenCoreAge Rx
WeighScore56.3/10089.5/100
GradeCB+
Site position#465#1
Semaglutide$375/mo (first-month rate, compounded)Product page from $79/mo; navigation $99. Confirm selected quote.
Tirzepatide$320/mo (starting dose, 3-month plan, compounded)From $129/mo advertised; confirm selected charge, supply and renewal.
Coverage5 statesUS only; therapy-specific state restrictions apply
Brand-name accessNot confirmedNot confirmed
Oral / sublingualYesNot confirmed
AquaVita NextGen

Site position #465 · C

Strengths

  • Physical address in Lake Forest CA
  • Named medical director (Dr. Steve Groke)
  • Both semaglutide and tirzepatide including ODT tablets
  • Compounding disclaimer present on site

What to consider

  • Only 5 states (AZ, CA, FL, TX, NV)
  • LegitScript or PCAB accreditation has not been independently verified
  • Primarily a local medspa expanding into telehealth
  • Only a first-month semaglutide price ($375, originally $499) is published; ongoing monthly price and all tirzepatide pricing remain unpublished
CoreAge Rx

Site position #1 · B+

Strengths

  • Current product pages advertise starting prices of $79 for semaglutide and $129 for tirzepatide
  • Advertises the same price across doses and no membership fee
  • Publishes cancellation, fulfillment and refund rules and a way to request the assigned pharmacy

What to consider

  • Starting prices vary across public displays and do not establish a selected invoice or usable prescription supply
  • FAQ no-rebill and payment-timing statements differ from the subscription and order policy
  • FAQ promises a full rejection refund, while policy retains an applicable $50–$100 consultation fee after review begins
  • Refund policy makes orders final after approval and pharmacy transmission; Terms also refer to review completion/transmission with policy exceptions. Confirm the cutoff and separate thirty-day documentation limit.
  • Actual clinician, dispenser, physical compounder, lab cost and treatment-state eligibility need confirmation

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard